Close Menu

You may find more results for this query on our sister sites: GenomeWeb and Precision Oncology News.

Home › Disease Areas › Infectious Disease › Hardy Diagnostics to Distribute EliTechGroup's Urogenital Mycoplasma Detection System

Hardy Diagnostics to Distribute EliTechGroup's Urogenital Mycoplasma Detection System

Mar 15, 2019
|
staff reporter

NEW YORK (360Dx) – Hardy Diagnostics said on Friday it has become an authorized distributor of EliTechGroup's Mycofast US, a system for detecting, enumerating, and identifying genital Mycoplasma hominis and Ureaplasma urealyticum.

Financial and other terms of the deal were not disclosed.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.

Oct
09
Featured Webinar

Navigating the FDA's EUA Process for Diagnostics in the Present and Future: A Stakeholder Panel Discussion

Sponsored by
PerkinElmer

As cases of COVID-19 continued to grow this spring and summer in the US, so too did the number of Emergency Use Authorizations from the FDA for clinical diagnostic tests aimed at detecting current and past infections.

What's Popular?

In Infectious Disease

  1. Roche SARS-CoV-2 Lateral Flow Antigen Test Could Meet Significant Demand

    Premium

  2. FDA Reissues Emergency Use Authorization for Hologic SARS-CoV-2 Assay for Asymptomatic Testing

  3. Cepheid Multiplex SARS-CoV-2, Flu, RSV Test Nabs FDA Emergency Use Authorization

  4. ASU Team Wins $6M in Government Funding to Develop Rapid Saliva Testing System for Coronavirus

  5. Commercial Coronavirus Antibody Tests Show Wide Variation in Accuracy in New Study

Sponsorships

Privacy Policy.  Terms & Conditions.  .  Copyright © 2020 GenomeWeb, a business unit of Crain Communications.  All Rights Reserved.